Medipines is an American medical equipment maker which is based in Orange County, California, United States.[2][3] It is known for its device, AGM100, which is approved for respiratory diagnosis and identifying the symptoms of COVID-19 using parameters such as oxygen saturation levels.[4] The device is being used in the Canada and the U.S.[5][6]
| Industry | Medical equipment |
|---|---|
| Headquarters | |
Key people | Steve Lee (CEO)[1] |
| Website | www |
History
editMediPines was incorporated in 2013.[7] They are known for their device, AGM100, which provides non-invasive pulmonary gas exchange measurements in a short period of time.[1] Approved by FDA, the device was developed in California and has been tested at the University of British Columbia.[8][9] It is in use in Canadian hospitals.[9]
In July 2020, it received the National Consortium for Pediatric Device award for developing a monitor device that displays a critical analysis of patients' breathing samples.[10][11]
In August 2021, the AGM100 was included in the WHO Compendium.[12]
References
edit- ^ a b "Portable, Non-Invasive Respiratory Monitoring System Helps Detect Presence of COVID-19 in At-Risk Elderly Population". 26 October 2020.
- ^ "Respiratory Device Reuse for Coronavirus". 30 April 2020.
- ^ "Merage Business School Brings Israeli Entrepreneurs".
- ^ "COVID-19:OC Case Rates Climb; Free Services May End Soon; Schools Lift Mask Mandates". OCBJ. 5 May 2022.
- ^ "Industry Watch". 8 June 2021.
- ^ "Alliston's Stevenson Memorial the only hospital in Canada using new device that measures lung capacity".
- ^ "Medipines Corp". Bloomberg News.
- ^ "Establishment Registration & Device Listing".
- ^ a b "Stevenson Memorial uses game-changing device with COVID-19 patients". 9 December 2020.
- ^ "Children's National UMD names COVID-19 Award recipients".
- ^ "STARTUPS & INNOVATIONS". OCBJ.
- ^ "WHO compendium".